{"id":1406,"date":"2022-04-21T00:27:51","date_gmt":"2022-04-20T21:27:51","guid":{"rendered":"https:\/\/www.sightsciences.com\/us\/?p=1406"},"modified":"2022-04-21T00:27:51","modified_gmt":"2022-04-20T21:27:51","slug":"sight-sciences-announces-multiple-presentations-and-event-at-the-2022-american-society-of-cataract-and-refractive-surgery-annual-meeting","status":"publish","type":"post","link":"https:\/\/www.sightsciences.com\/us\/sight-sciences-announces-multiple-presentations-and-event-at-the-2022-american-society-of-cataract-and-refractive-surgery-annual-meeting\/","title":{"rendered":"Sight Sciences Announces Multiple Presentations and Event at the 2022 American Society of Cataract and Refractive Surgery Annual Meeting"},"content":{"rendered":"<div class=\"file-link pdf-file-link\"><span class=\"file file--mime-application-pdf file--application-pdf\"><a href=\"https:\/\/investors.sightsciences.com\/node\/7241\/pdf\" target=\"_blank\" rel=\"noopener\">PDF Version<\/a><\/span><\/div>\n<div class=\"node__content\">\n<div class=\"box__wrap\"><\/div>\n<p align=\"left\">MENLO PARK, Calif., April 20, 2022 (GLOBE NEWSWIRE) &#8212;\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fODWbJ85NvTDBvTyKJfifuBjhJV1VGDBSODnFnC8vWrO8CsglTqFrFGbZsC-zJ6kf1kgXZWPmq9OrdJj2_V0XcJ7a_ZIApHiJ6aihHQwOhg=\" target=\"_blank\" rel=\"nofollow noopener\"><u>Sight Sciences, Inc.<\/u><\/a>\u00a0(Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients\u2019 lives, today announced that data from clinical studies of the OMNI<sup>\u00ae<\/sup>\u00a0Surgical System will be presented at the 2022 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting. Additionally, the Company is sponsoring a minimally invasive glaucoma surgery (MIGS) education symposium. The conference will take place April 22-26, 2022 at the Walter E. Washington Convention Center in Washington, D.C.<\/p>\n<p><br class=\"\"><\/p>\n<p align=\"left\"><strong>Poster\/Paper Presentations:<\/strong><\/p>\n<p><br class=\"\"><br \/>\nThree posters have been accepted for presentation. Details of the presentations are as follows:<br class=\"\"><br \/>\nSession Title: \u201cOutcomes of Canaloplasty and Trabeculotomy in Eyes with Previous Trabecular Micro-Bypass Implantation\u201d<br \/>\nPresenter: Arkadiy Yadgarov, MD, ABO; Anita Campbell, MD, ABO<br \/>\nLocation: WEWCC<br \/>\nDate and Time: Friday, April 22; 8:45-8:50 AM ET<br class=\"\"><br \/>\nSession Title: \u201cIOP Fluctuations and Visual Field Status: Fluctuation Suppression with Combined Canaloplasty and Trabeculotomy in Open-Angle Glaucoma\u201d<br \/>\nPresenter: Mark F. Pyfer, MD, FACS; Brandon J. Baartman, MD; Inder P. Singh, MD<br \/>\nLocation: WEWCC \u2013 Level 1, 143B<br \/>\nDate and Time: Saturday, April 23; 8:51-8:56 AM ET<br class=\"\"><br \/>\nSession Title: \u201cCanaloplasty and Trabeculotomy Ab Interno Combined with Cataract Surgery: 12-Month Outcomes in Hispanic Patients with Open-Angle Glaucoma\u201d<br \/>\nPresenter: Mark J. Gallardo, MD<br \/>\nLocation: WEWCC \u2013 Level 1, 144B<br \/>\nDate and Time: Monday, April 25; 2:08-2:13 PM ET<br class=\"\"><br \/>\n<strong>Event:<\/strong><br class=\"\"><br \/>\nSight Sciences will host an educational symposium, \u201cMIGS Beyond Cataract Surgery: An Interventional Mindset\u201d moderated by Thomas Samuelson, MD, former president of ASCRS, on Friday, April 22 at 6:00 pm ET. The program will include a clinical discussion and interactive Q&amp;A session featuring the OMNI<sup>\u00ae<\/sup>\u00a0Surgical System and highlighting the benefits of stent-free MIGS. Registration is available\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uxM_o5alBqO6SZLOqulZhaEPiu8BXK5_cTvOdBpVNxpyerpljwfSAbGaOTtiaEGILcWRDv8qE7_8p4_6VJCY5WxxwqcCYf7wKb8bXlrYesgs6q_hYxbtZxhMEbqhsyWn\" target=\"_blank\" rel=\"nofollow noopener\">here<\/a>.<br class=\"\"><br \/>\n<strong>About Sight Sciences<\/strong><br class=\"\"><br \/>\nSight Sciences is an eyecare technology company focused on developing and commercializing innovative solutions intended to transform care and improve patients\u2019 lives. Using minimally invasive or non-invasive approaches to target the underlying causes of the world\u2019s most prevalent eye diseases, Sight Sciences seeks to create more effective treatment paradigms that enhance patient care and supplant conventional outdated approaches. The Company\u2019s OMNI<sup>\u00ae<\/sup>\u00a0Surgical System is a minimally invasive glaucoma surgery (MIGS) device indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma (POAG), the world\u2019s leading cause of irreversible blindness. The Company\u2019s TearCare<sup>\u00ae<\/sup>\u00a0System is 510(k) cleared for the application of localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland dysfunction (MGD), enabling office-based clearance of gland obstructions by physicians to address the leading cause of dry eye disease.<br class=\"\"><br \/>\nFor more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kWI6KWXfssaCU6BSdhU9H6Z7msvglm9sh17PrAP9PlOWj_Iz4FJTkIiLYThMlsIXo66M96FzCYMEmotfU1eKdeGu_SdQfXdlhDjDHmrPnaY=\" target=\"_blank\" rel=\"nofollow noopener\">www.sightsciences.com<\/a>.<br class=\"\"><br \/>\n<strong>About the OMNI<\/strong><sup><strong>\u00ae<\/strong><\/sup><strong>\u00a0Surgical System<\/strong><br class=\"\"><br \/>\nThe OMNI<sup><strong>\u00ae<\/strong><\/sup>\u00a0Surgical System is a handheld, single-use therapeutic device for minimally invasive glaucoma surgery (MIGS). It is indicated for canaloplasty (the microcatheterization and viscodilation of Schlemm\u2019s canal) followed by trabeculotomy (the cutting of trabecular meshwork) to reduce intraocular pressure in adult patients with primary open-angle glaucoma.<br class=\"\"><br \/>\nOMNI<sup><strong>\u00ae<\/strong><\/sup>\u00a0allows surgeons to access 360 degrees and three primary points of resistance of an eye\u2019s diseased conventional outflow pathway (trabecular meshwork, Schlemm\u2019s canal, and collector channels) through a single clear corneal microincision.<br class=\"\"><br \/>\nOMNI<sup><strong>\u00ae<\/strong><\/sup>\u00a0is indicated by the FDA for canaloplasty (the microcatheterization and viscodilation of Schlemm\u2019s canal) followed by trabeculotomy (the cutting of trabecular meshwork) to reduce intraocular pressure in adult patients with primary open-angle glaucoma. OMNI has a CE Mark for the catheterization and transluminal viscodilation of Schlemm\u2019s canal and the cutting of trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma.<br class=\"\"><br \/>\nOMNI<sup><strong>\u00ae<\/strong><\/sup>\u00a0should not be used in any situations where the iridocorneal angle is compromised or has been damaged since it may not be possible to visualize the angle or to properly pass the microcatheter. Do not use the OMNI\u00ae in patients with angle recession; neovascular glaucoma; chronic angle closure; narrow-angle glaucoma; traumatic or malignant glaucoma; or narrow inlet canals with plateau iris or in quadrants with previous MIGS implants.<br class=\"\"><br \/>\nOMNI<sup><strong>\u00ae<\/strong><\/sup>\u00a0received its first FDA clearance in 2017 and is protected by a global patent portfolio including 32 issued patents worldwide.<br class=\"\"><br \/>\nOMNI<sup><strong>\u00ae<\/strong><\/sup>\u00a0is a registered trademark of Sight Sciences.<br class=\"\"><br \/>\n<strong>Forward-Looking Statements<\/strong><br class=\"\"><br \/>\nThis press release, together with other statements and information publicly disseminated by the Company, contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 and includes this statement for purposes of complying with these safe harbor provisions. Any statements made in this press release that are not statements of historical fact, including statements about our beliefs and expectations, are forward-looking statements and should be evaluated as such. Forward-looking statements include information concerning possible or assumed future results of operations, including descriptions of our business plan and strategies. These statements often include words such as \u201canticipate,\u201d \u201cexpect,\u201d \u201csuggests,\u201d \u201cplan,\u201d \u201cbelieve,\u201d \u201cintend,\u201d \u201cestimates,\u201d \u201ctargets,\u201d \u201cprojects,\u201d \u201cshould,\u201d \u201ccould,\u201d \u201cwould,\u201d \u201cmay,\u201d \u201cwill,\u201d \u201cforecast\u201d and other similar expressions. We base these forward-looking statements on our current expectations, plans and assumptions that we have made in light of our experience in the industry, as well as our perceptions of historical trends, current conditions, expected future developments and other factors we believe are appropriate under the circumstances at such time. Although we believe that these forward-looking statements are based on reasonable assumptions at the time they are made, you should be aware that many factors could affect our business, results of operations and financial condition and could cause actual results to differ materially from those expressed in the forward-looking statements. These statements are not guarantees of future performance or results. The forward-looking statements are subject to and involve risks, uncertainties and assumptions, and you should not place undue reliance on these forward-looking statements. These forward-looking statements include, but are not limited to, statements concerning the following: estimates of our total addressable market, future revenue, expenses, capital requirements, and our needs for additional financing; our ability to enter into and compete in new markets; the impact of the COVID-19 pandemic on our business, our customers\u2019 and suppliers\u2019 businesses and the general economy; our ability to compete effectively with existing competitors and new market entrants; our ability to scale our infrastructure; our ability to manage and grow our business by expanding our sales to existing customers or introducing our products to new customers; our ability to establish and maintain intellectual property protection for our products or avoid claims of infringement; potential effects of extensive government regulation; our abilities to obtain and maintain regulatory approvals and clearances for our products that support our revenue projections, business strategies and growth; our ability to successfully execute our clinical trial roadmap; our ability to obtain and maintain sufficient reimbursement for our products; our abilities to protect and scale our intellectual property portfolio; our ability to hire and retain key personnel; our ability to obtain financing in future offerings; the volatility of the trading price of our common stock; our expectation regarding the time during which we will be an emerging growth company under the Jumpstart Our Business Startups Act (the \u201cJOBS Act\u201d); our ability to maintain proper and effective internal controls; and the other important factors discussed under the caption \u201cRisk Factors\u201d in our filings with the U.S. Securities and Exchange Commission, as may be updated from time to time in subsequent filings. These cautionary statements should not be construed by you to be exhaustive and are made only as of the date of this press release. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.<br class=\"\"><br \/>\n<strong>Media contact:<\/strong><br \/>\nShay Smith<br \/>\nHealth+Commerce<br \/>\n707.971.9779<br \/>\n<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_Pqb-MN1UgZFNkvAOC2ZOMi8KhntRFSj8c3tioCHN0ZOih3crfYAMUZ4HPk4qg8BeJpXX5tAGQoyYysq5M1Qu7WpY5V4ZKAEtBZlyjmHYysJdA3BwZVrzxtUyqAyHML0\" target=\"_blank\" rel=\"nofollow noopener\">shay@healthandcommerce.com<\/a><br class=\"\"><br \/>\n<strong>Investor contact:<\/strong><br \/>\nPhilip Taylor<br \/>\nGilmartin Group<br \/>\n415.937.5406<br \/>\n<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wryYl7TWxLIHXs-czW8JwuVinfGjYXpP5Jr7W8KSy7r3G1V6uqMcRTXOBiqr3sKmFsialKvH3Znhnf0y3Nj2XiENlTcA1M3oCM9J8qHHH4_viWXjuw3lJrPyhU0Ca25CEcfb_WqIYakZK7sZBLKlRw==\" target=\"_blank\" rel=\"nofollow noopener\">Investor.Relations@Sightsciences.com<\/a>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>PDF Version MENLO PARK, Calif., April 20, 2022 (GLOBE NEWSWIRE) &#8212;\u00a0Sight Sciences, Inc.\u00a0(Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients\u2019 lives, today announced that data from clinical studies of the OMNI\u00ae\u00a0Surgical System will be presented at the 2022 American Society of Cataract and Refractive Surgery [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[6],"tags":[],"class_list":["post-1406","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.4 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Sight Sciences Announces Multiple Presentations and Event at the 2022 American Society of Cataract and Refractive Surgery Annual Meeting - United States<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sightsciences.com\/us\/sight-sciences-announces-multiple-presentations-and-event-at-the-2022-american-society-of-cataract-and-refractive-surgery-annual-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sight Sciences Announces Multiple Presentations and Event at the 2022 American Society of Cataract and Refractive Surgery Annual Meeting\" \/>\n<meta property=\"og:description\" content=\"PDF Version MENLO PARK, Calif., April 20, 2022 (GLOBE NEWSWIRE) &#8212;\u00a0Sight Sciences, Inc.\u00a0(Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients\u2019 lives, today announced that data from clinical studies of the OMNI\u00ae\u00a0Surgical System will be presented at the 2022 American Society of Cataract and Refractive Surgery [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sightsciences.com\/us\/sight-sciences-announces-multiple-presentations-and-event-at-the-2022-american-society-of-cataract-and-refractive-surgery-annual-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta property=\"article:published_time\" content=\"2022-04-20T21:27:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sightsciences.com\/us\/wp-content\/uploads\/sites\/4\/2024\/04\/SISC_RTS_Logo_Primary_RGB_P1-1200.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin-dev\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin-dev\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/sight-sciences-announces-multiple-presentations-and-event-at-the-2022-american-society-of-cataract-and-refractive-surgery-annual-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/sight-sciences-announces-multiple-presentations-and-event-at-the-2022-american-society-of-cataract-and-refractive-surgery-annual-meeting\\\/\"},\"author\":{\"name\":\"admin-dev\",\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/#\\\/schema\\\/person\\\/88f84507b2364aa1168168756f61f091\"},\"headline\":\"Sight Sciences Announces Multiple Presentations and Event at the 2022 American Society of Cataract and Refractive Surgery Annual Meeting\",\"datePublished\":\"2022-04-20T21:27:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/sight-sciences-announces-multiple-presentations-and-event-at-the-2022-american-society-of-cataract-and-refractive-surgery-annual-meeting\\\/\"},\"wordCount\":1323,\"commentCount\":0,\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/sight-sciences-announces-multiple-presentations-and-event-at-the-2022-american-society-of-cataract-and-refractive-surgery-annual-meeting\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/sight-sciences-announces-multiple-presentations-and-event-at-the-2022-american-society-of-cataract-and-refractive-surgery-annual-meeting\\\/\",\"url\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/sight-sciences-announces-multiple-presentations-and-event-at-the-2022-american-society-of-cataract-and-refractive-surgery-annual-meeting\\\/\",\"name\":\"Sight Sciences Announces Multiple Presentations and Event at the 2022 American Society of Cataract and Refractive Surgery Annual Meeting - United States\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/#website\"},\"datePublished\":\"2022-04-20T21:27:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/#\\\/schema\\\/person\\\/88f84507b2364aa1168168756f61f091\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/sight-sciences-announces-multiple-presentations-and-event-at-the-2022-american-society-of-cataract-and-refractive-surgery-annual-meeting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/sight-sciences-announces-multiple-presentations-and-event-at-the-2022-american-society-of-cataract-and-refractive-surgery-annual-meeting\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/sight-sciences-announces-multiple-presentations-and-event-at-the-2022-american-society-of-cataract-and-refractive-surgery-annual-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sight Sciences Announces Multiple Presentations and Event at the 2022 American Society of Cataract and Refractive Surgery Annual Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/#\\\/schema\\\/person\\\/88f84507b2364aa1168168756f61f091\",\"name\":\"admin-dev\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7b9b8f03f53de455547cff48e35299ac8abad46d269b304aaf6215427c968767?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7b9b8f03f53de455547cff48e35299ac8abad46d269b304aaf6215427c968767?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7b9b8f03f53de455547cff48e35299ac8abad46d269b304aaf6215427c968767?s=96&d=mm&r=g\",\"caption\":\"admin-dev\"},\"url\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/author\\\/admin-dev\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Sight Sciences Announces Multiple Presentations and Event at the 2022 American Society of Cataract and Refractive Surgery Annual Meeting - United States","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sightsciences.com\/us\/sight-sciences-announces-multiple-presentations-and-event-at-the-2022-american-society-of-cataract-and-refractive-surgery-annual-meeting\/","og_locale":"en_US","og_type":"article","og_title":"Sight Sciences Announces Multiple Presentations and Event at the 2022 American Society of Cataract and Refractive Surgery Annual Meeting","og_description":"PDF Version MENLO PARK, Calif., April 20, 2022 (GLOBE NEWSWIRE) &#8212;\u00a0Sight Sciences, Inc.\u00a0(Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients\u2019 lives, today announced that data from clinical studies of the OMNI\u00ae\u00a0Surgical System will be presented at the 2022 American Society of Cataract and Refractive Surgery [&hellip;]","og_url":"https:\/\/www.sightsciences.com\/us\/sight-sciences-announces-multiple-presentations-and-event-at-the-2022-american-society-of-cataract-and-refractive-surgery-annual-meeting\/","og_site_name":"United States","article_published_time":"2022-04-20T21:27:51+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.sightsciences.com\/us\/wp-content\/uploads\/sites\/4\/2024\/04\/SISC_RTS_Logo_Primary_RGB_P1-1200.png","type":"image\/png"}],"author":"admin-dev","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin-dev","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.sightsciences.com\/us\/sight-sciences-announces-multiple-presentations-and-event-at-the-2022-american-society-of-cataract-and-refractive-surgery-annual-meeting\/#article","isPartOf":{"@id":"https:\/\/www.sightsciences.com\/us\/sight-sciences-announces-multiple-presentations-and-event-at-the-2022-american-society-of-cataract-and-refractive-surgery-annual-meeting\/"},"author":{"name":"admin-dev","@id":"https:\/\/www.sightsciences.com\/us\/#\/schema\/person\/88f84507b2364aa1168168756f61f091"},"headline":"Sight Sciences Announces Multiple Presentations and Event at the 2022 American Society of Cataract and Refractive Surgery Annual Meeting","datePublished":"2022-04-20T21:27:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.sightsciences.com\/us\/sight-sciences-announces-multiple-presentations-and-event-at-the-2022-american-society-of-cataract-and-refractive-surgery-annual-meeting\/"},"wordCount":1323,"commentCount":0,"articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.sightsciences.com\/us\/sight-sciences-announces-multiple-presentations-and-event-at-the-2022-american-society-of-cataract-and-refractive-surgery-annual-meeting\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.sightsciences.com\/us\/sight-sciences-announces-multiple-presentations-and-event-at-the-2022-american-society-of-cataract-and-refractive-surgery-annual-meeting\/","url":"https:\/\/www.sightsciences.com\/us\/sight-sciences-announces-multiple-presentations-and-event-at-the-2022-american-society-of-cataract-and-refractive-surgery-annual-meeting\/","name":"Sight Sciences Announces Multiple Presentations and Event at the 2022 American Society of Cataract and Refractive Surgery Annual Meeting - United States","isPartOf":{"@id":"https:\/\/www.sightsciences.com\/us\/#website"},"datePublished":"2022-04-20T21:27:51+00:00","author":{"@id":"https:\/\/www.sightsciences.com\/us\/#\/schema\/person\/88f84507b2364aa1168168756f61f091"},"breadcrumb":{"@id":"https:\/\/www.sightsciences.com\/us\/sight-sciences-announces-multiple-presentations-and-event-at-the-2022-american-society-of-cataract-and-refractive-surgery-annual-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sightsciences.com\/us\/sight-sciences-announces-multiple-presentations-and-event-at-the-2022-american-society-of-cataract-and-refractive-surgery-annual-meeting\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.sightsciences.com\/us\/sight-sciences-announces-multiple-presentations-and-event-at-the-2022-american-society-of-cataract-and-refractive-surgery-annual-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sightsciences.com\/us\/"},{"@type":"ListItem","position":2,"name":"Sight Sciences Announces Multiple Presentations and Event at the 2022 American Society of Cataract and Refractive Surgery Annual Meeting"}]},{"@type":"WebSite","@id":"https:\/\/www.sightsciences.com\/us\/#website","url":"https:\/\/www.sightsciences.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sightsciences.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.sightsciences.com\/us\/#\/schema\/person\/88f84507b2364aa1168168756f61f091","name":"admin-dev","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/7b9b8f03f53de455547cff48e35299ac8abad46d269b304aaf6215427c968767?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/7b9b8f03f53de455547cff48e35299ac8abad46d269b304aaf6215427c968767?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7b9b8f03f53de455547cff48e35299ac8abad46d269b304aaf6215427c968767?s=96&d=mm&r=g","caption":"admin-dev"},"url":"https:\/\/www.sightsciences.com\/us\/author\/admin-dev\/"}]}},"_links":{"self":[{"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/posts\/1406","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/comments?post=1406"}],"version-history":[{"count":0,"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/posts\/1406\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/media?parent=1406"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/categories?post=1406"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/tags?post=1406"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}